Several studies have validated the hypothesis that preeclampsia arises due to ‘increase in the level of endogenous soluble Flt-1 (sFlt-1) that may antagonize the beneficial effects of vascular endothelial growth factor (VEGF)’[[10], [11], [12], [13]]. The gene discussed is VEGFA; the disease is preeclampsia.